Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...

The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...

Drugmaker Novo Nordisk said Costco pharmacies will sell the prescription drugs Ozempic and Wegovy for $499 for self-pay ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

Five top-selling drugs, in some cases, are costing Americans thousands in out of pocket expenses weekly and monthly. Here's ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Recently, an Iowa-based pharma company is dragged in an Ozempic lawsuit, reason? For selling counterfeit Ozempic. Ozempic is a popular drug used for diabetes and weight-loss. Its official website ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...